Morning Market Losers
March 23, 2015 at 10:02 AM EDT
MEI Pharma, Inc. (NASDAQ: MEIP) shares dipped 68.73% to $1.97 on failed Pracinostat and azacitidine Phase II study. Global-Tech ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.